Overview

Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This study is a prospective randomized clinical controlled trial to assess the efficacy of the Methylprednisolone for preventing ovarian hyper stimulation syndrome in in vitro fertilization (IVF) cycles.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Royan Institute
Treatments:
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate